Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
Astera Labs Inc (NASDAQ: ALAB) closed the day trading at $170.1 up 1.70% from the previous closing price of $167.26. In other words, the price has increased by $1.70 from its previous closing price. On the day, 1.92 million shares were traded. ALAB stock price reached its highest trading level at $170.61 during the session, while it also had its lowest trading level at $160.8.
Ratios:
For a better understanding of ALAB, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 25.30 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 125.22. For the most recent quarter (mrq), Quick Ratio is recorded 12.27 and its Current Ratio is at 12.78. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
On November 20, 2025, BNP Paribas Exane started tracking the stock assigning a Outperform rating and target price of $225.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 01 ’25 when ALBA MANUEL sold 33,000 shares for $166.18 per share. The transaction valued at 5,483,981 led to the insider holds 352,863 shares of the business.
ALBA MANUEL sold 150,000 shares of ALAB for $24,927,221 on Dec 01 ’25. The Director now owns 1,574,498 shares after completing the transaction at $166.18 per share. On Dec 01 ’25, another insider, MAR 2011 CHILDRENS TRUST U/A D, who serves as the Director of the company, bought 170,000 shares for $157.57 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALAB now has a Market Capitalization of 28731348992 and an Enterprise Value of 27628242944. As of this moment, Astera’s Price-to-Earnings (P/E) ratio for their current fiscal year is 151.45, and their Forward P/E ratio for the next fiscal year is 70.54. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.24. For the stock, the TTM Price-to-Sale (P/S) ratio is 39.74 while its Price-to-Book (P/B) ratio in mrq is 22.59. Its current Enterprise Value per Revenue stands at 38.211 whereas that against EBITDA is 247.64.
Stock Price History:
The Beta on a monthly basis for ALAB is 1.52, which has changed by 0.2628162 over the last 52 weeks, in comparison to a change of 0.17823458 over the same period for the S&P500. Over the past 52 weeks, ALAB has reached a high of $262.90, while it has fallen to a 52-week low of $47.12. The 50-Day Moving Average of the stock is 6.39%, while the 200-Day Moving Average is calculated to be 27.85%.
Shares Statistics:
Over the past 3-months, ALAB traded about 6.02M shares per day on average, while over the past 10 days, ALAB traded about 4756770 shares per day. A total of 168.90M shares are outstanding, with a floating share count of 134.35M. Insiders hold about 20.46% of the company’s shares, while institutions hold 66.31% stake in the company. Shares short for ALAB as of 1765756800 were 12293014 with a Short Ratio of 2.04, compared to 1763078400 on 10645508. Therefore, it implies a Short% of Shares Outstanding of 12293014 and a Short% of Float of 9.8400004.
Earnings Estimates
Astera Labs Inc (ALAB) is currently under the scrutiny of 19.0 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is $0.52, with high estimates of $0.56 and low estimates of $0.47.
Analysts are recommending an EPS of between $1.8 and $1.76 for the fiscal current year, implying an average EPS of $1.78. EPS for the following year is $2.37, with 19.0 analysts recommending between $2.81 and $2.0.
Revenue Estimates
17 analysts predict $249.46M in revenue for. The current quarter. It ranges from a high estimate of $251.3M to a low estimate of $248.9M. As of. The current estimate, Astera Labs Inc’s year-ago sales were $141.1MFor the next quarter, 17 analysts are estimating revenue of $258.71M. There is a high estimate of $266.45M for the next quarter, whereas the lowest estimate is $249.1M.
A total of 21 analysts have provided revenue estimates for ALAB’s current fiscal year. The highest revenue estimate was $833.3M, while the lowest revenue estimate was $774.54M, resulting in an average revenue estimate of $827.5M. In the same quarter a year ago, actual revenue was $396.29MBased on 19 analysts’ estimates, the company’s revenue will be $1.18B in the next fiscal year. The high estimate is $1.33B and the low estimate is $1.07B.
